NCT04440943 A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT04437030 Multiparametric Photoacoustic Imaging in the Course of Radiation Therapy of Malignant Head and Neck Tumors Status COMPLETED Phase NA
NCT04435964 Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatment Status COMPLETED Phase N/A
NCT04431648 Novel MRI-Guided Ultrasound Stimulated Microbubble Radiation Treatment for Patients With Head and Neck Cancer Status RECRUITING Phase PHASE1
NCT04430842 Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S Status COMPLETED Phase PHASE1
NCT04428515 Pilot Study to Evaluate Photoacoustic Imaging in Head and Neck Cancer Status RECRUITING Phase N/A
NCT04408898 SPEARHEAD 2 Study in Subjects With Recurrent or Metastatic Head and Neck Cancer Status WITHDRAWN Phase PHASE2
NCT04383210 Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors Status TERMINATED Phase PHASE2
NCT04379505 Palliative Expeditiously Adaptive Quad Shot Radiation Therapy (PEAQ-RT) Status COMPLETED Phase NA
NCT04379232 Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center Status COMPLETED Phase N/A
NCT04373642 "QUAD SHOT" Radiotherapy With Pembrolizumab in Patients With Recurrent Head & Neck Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04354064 Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors Status RECRUITING Phase N/A
NCT04338399 The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC Status COMPLETED Phase PHASE3
NCT04326088 Postoperative Complication After Free Flap Reconstruction for Head and Neck Cancer Status COMPLETED Phase N/A
NCT04322695 A Rehabilitation Education Care Program on Return to Work Among Head and Neck Cancer Survivors Status UNKNOWN Phase NA
NCT04313504 Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Recurrent/Metastatic HNSCC Status COMPLETED Phase PHASE2
NCT04308525 Optimising Microsurgical Reconstruction After Advanced Head and Neck Cancers Status UNKNOWN Phase N/A